NeOnc Technologies Holdings, Inc. (Nasdaq Global Market: NTHI), a clinical-stage medical biotechnology company, today announced a strategic partnership with CBCC Global Research (CBCC), a premier full ...

Firefighters show higher rates of glioma-linked SBS42 mutational signatures associated with haloalkane exposure, suggesting ...

An 18-year-old has revealed how she was tested for countless illnesses throughout 2024 until an unusual symptom exposed the ...

Actinium Pharma inks research pact with Memorial Sloan Kettering to support further clinical expansion of Actimab-A's backbone therapy strategy: New York Saturday, March 22, 2025, ...

Actinium Pharmaceuticals (ATNM) has entered into a sponsored research agreement with Memorial Sloan Kettering Cancer Center to expand ...

You would think a brain cancer diagnosis would water down your sense of humour – but this brave young girl is laughing in the ...

“We were surprised to discover that KMT could work synergistically with the IDH1 mutation to simultaneously target the ... including the Foundation for Metabolic Cancer Therapies, Children with Cancer ...

The researchers developed a UR-ddPCR assay for the IDH1 R132H mutation that accurately ... a molecular diagnosis during surgery for brain cancer," co-senior author Gilad D. Evrony, M.D., Ph.D ...